MyCelx Technologies Corporation Trading Update (4135B)

TIDMMYX TIDMTTM

RNS Number : 4135B

MyCelx Technologies Corporation

11 February 2022

11 February 2022

MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)

Trading Update

MYCELX Technologies Corporation ("MYCELX" or the "Company"), the clean water and clean air technology company, is pleased to announce a trading update on the Company's operations.

Highlights

   --    Anticipated unaudited 2021 revenue of ca.$8.5 million (2020: $7.1 million) 

-- As at 31 December 2021, the Company had cash and cash equivalents, including restricted cash, of $3.2 million (2021 H1: $5.5 million), and the Company continues to manage its working capital and support growth

-- Operations continue to perform in line with expectations, with minimal to no impact of Covid-19 in MYCELX's day-to-day business functions

-- In 2022 the Company is targeting a similar level of year-on-year revenue growth but this remains subject to the timing of anticipated contract wins and renewals

Commenting on these results, Connie Mixon, CEO, said:

"We are very pleased with how the Company performed in the second half of 2021 and based on the start of the year, we are targeting to deliver year-on-year growth to our stakeholders in 2022. Oil prices are at their highest levels since 2014, which we anticipate will lead to greater levels of production activity across the regions in which we operate and will likely lead to heightened demand for our environmental solutions in these areas.

We were pleased to report a successful outcome at our PFAS trial in the United States in December, as we believe the PFAS remediation market has the potential to generate substantial cash flows for the business for the foreseeable future.

Finally, we continue to successfully navigate the Covid-19 pandemic, with the Company now experiencing little to no impact on its day-to-day operations. However, we continue to take all precautions necessary in order to safeguard the welfare of our workforce."

For further information, please contact:

 
MYCELX Technologies Corporation 
 Connie Mixon, CEO                                     Tel: [phone] 
 Kim Slayton, CFO 
 
  Canaccord Genuity Limited (Nomad and Sole Broker)    Tel: [phone] 
  Henry Fitzgerald-O'Connor 
  Gordon Hamilton 
Celicourt Communications (Financial PR) 
 Mark Antelme                                          Tel: [phone] 
 Jimmy Lea 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TSTSFDSMFEESEFE

(END) Dow Jones Newswires

February 11, 2022 02:00 ET (07:00 GMT)